Antal Szalay, MD, MBA

Dr. Antal Szalay is the founding CEO and CSO of Ultimate Medicine, a Swiss biotechnology company developing first-in-class therapeutics that target gut-brain metabolites linked to cognitive decline and dementia. A physician-scientist and entrepreneur, Dr. Szalay co-discovered the gut-brain metabolite pathway with Dr. Thomas Blank at the University of Freiburg, leading to key publications in Nature Aging and Nature Neuroscience and forming the scientific foundation for Ultimate Medicine’s platform.

Before founding the company, Dr. Szalay served as Medical Director and Medical Board Member at AMEOS Group in Zurich, where he led clinical innovation across psychiatric and psychosomatic medicine. His earlier career combined patient care and translational neuroscience at leading European institutions.

Dr. Szalay earned his MD from the University of Giessen, a Doctorate from the University of Freiburg, an MBA from the University of St. Gallen, and completed advanced analytics training at Harvard University.

Through his partnership with Freiburg, Dr. Szalay drives Ultimate Medicine’s mission to restore brain health via a new class of gut-brain therapeutics